Literature DB >> 14989745

Malignant eccrine spiradenoma: a case report with pulmonary metastasis.

Shih-Cheng Chou1, Shong-Ling Lin, Hui-Hwa Tseng.   

Abstract

Malignant eccrine spiradenoma is an extremely rare sweat gland tumor. It may develop de novo or arise in pre-existing benign eccrine spiradenoma. However, most tumors are presented in the latter mode. The case of a 50-year-old man with malignant transformation from previously existing benign eccrine spiradenoma over his right lateral thigh is reported. Evidence for this diagnosis includes two distinct morphological components. One is the well demarcated, small round to oval benign eccrine spiradenoma and the other is the malignant element with sarcomatoid differentiation. Some foci of transition between the benign eccrine spiradenoma and the sarcomatoid part are evident and represents that the latter may arise from the former. Whether different morphological patterns influence the patients' outcome is still doubtful. However, the malignant eccrine spiradenoma is thought to have the capacity of metastasis and lethal potentiality.

Entities:  

Mesh:

Year:  2004        PMID: 14989745     DOI: 10.1111/j.1440-1827.2004.01609.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  5 in total

1.  Multiple Segmental Eccrine Spiradenoma with a Zosteriform Pattern: A Case Report and Literature Review.

Authors:  Fang Ren; Zhili Hu; Qingtao Kong; Hong Sang
Journal:  Ann Dermatol       Date:  2015-07-29       Impact factor: 1.444

2.  A rare case of multiple segmental eccrine spiradenomas.

Authors:  Laura Englander; Jason J Emer; Danielle McClain; Bijal Amin; Ryan B Turner
Journal:  J Clin Aesthet Dermatol       Date:  2011-04

3.  Direct intracranial extension of malignant eccrine spiradenoma of the face.

Authors:  Srinivas B Pedamallu; Justin Murphy; Douglas Boyd; Dominic Martin-Hirsch; Khaled Al-Zwae
Journal:  J Clin Med Res       Date:  2009-08-20

Review 4.  Current Treatment Options for Cutaneous Adnexal Malignancies.

Authors:  Hiroyuki Goto
Journal:  Curr Treat Options Oncol       Date:  2022-03-26

Review 5.  Update of cylindromatosis gene (CYLD) mutations in Brooke-Spiegler syndrome: novel insights into the role of deubiquitination in cell signaling.

Authors:  Patrick W Blake; Jorge R Toro
Journal:  Hum Mutat       Date:  2009-07       Impact factor: 4.878

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.